Ginkgo Bioworks Ownership | Who Owns Ginkgo Bioworks?


OverviewForecastRevenueFinancialsChartTranscripts

Ginkgo Bioworks Ownership Summary


Ginkgo Bioworks is owned by 46.14% institutional investors, 6.44% insiders, and 47.41% retail investors. Blackrock is the largest institutional shareholder, holding 2.10% of DNA shares. MS INVF US Growth I is the top mutual fund, with 12.38% of its assets in Ginkgo Bioworks shares.

DNA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGinkgo Bioworks46.14%6.44%47.41%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock42.01M2.10%$14.04M
Two sigma advisers, lp31.44M1.57%$10.51M
Two sigma investments, lp19.41M0.97%$6.49M
D. e. shaw17.36M0.87%$5.80M
Norges bank15.63M0.78%$5.22M
Geode capital management15.31M0.76%$5.12M
Aqr capital management10.36M0.52%$3.39M
State street10.09M0.50%$3.37M
Charles schwab investment management6.69M0.33%$2.23M
Morgan stanley6.00M0.30%$2.01M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boston standard wealth management606.63K0.04%$203.00K
Ctc alternative strategies169.30K0.02%$56.60K
Two sigma advisers, lp31.44M0.02%$10.51M
Two sigma investments, lp19.41M0.01%$6.49M
D. e. shaw17.36M0.01%$5.80M
Aqr capital management10.36M0.01%$3.39M
Pine valley investments ltd liability220.61K0.00%$73.75K
Teachers retirement system of the state of kentucky857.99K0.00%$287.00K
Jpl wealth management10.00K0.00%$3.34K
Group one trading1.16M0.00%$386.55K

Top Buyers

HolderShares% AssetsChange
Two sigma advisers, lp31.44M0.02%30.31M
Two sigma investments, lp19.41M0.01%19.30M
D. e. shaw17.36M0.01%17.27M
Norges bank15.63M0.00%15.63M
Aqr capital management10.36M0.01%10.36M

Top Sellers

HolderShares% AssetsChange
Viking global investors lp---143.09M
Vanguard group---138.96M
Baillie gifford---134.43M
Anchorage capital group---69.85M
Morgan stanley6.00M0.00%-43.07M

New Positions

HolderShares% AssetsChangeValue
Norges bank15.63M0.00%15.63M$5.22M
Mackenzie financial749.77K0.00%749.77K$250.65K
Ctc alternative strategies169.30K0.02%169.30K$56.60K
Lpl financial55.00K-55.00K$18.39K
Macquarie group52.42K-52.42K$17.53K

Sold Out

HolderChange
Baldwin brothers llc/ma-10.00
Headlands-19.00
Financial gravity asset management-65.00
Triad wealth partners-100.00
Planning capital management-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024319-7.54%924,893,756-27.25%461.08%115-30.72%10917.20%
Mar 31, 2024345-1.99%1,271,408,6251.48%651.59%1667.79%93-6.06%
Dec 31, 2023352-1.12%1,252,917,5662.89%641.62%154-21.43%9970.69%
Sep 30, 202335610.22%1,217,746,1251.28%621.60%19620.25%58-4.92%
Jun 30, 20233230.62%1,202,407,7456.23%621.80%1637.95%61-21.79%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
MS INVF US Growth I6.88M12.38%-
Nikko Gbl All Biological Genome Eq MF4.97M8.95%-848.04K
AQR Style Premia Alternative I2.67M4.80%2.67M
Baillie Gifford US Growth Ord2.24M4.03%-
ARK Disruptive Innovation Full Composite1.91M3.43%-121.99M
Vanguard Advice Select Intl Gr Admiral1.66M2.98%-
Russell Personalized DI All Cap SMA1.57M2.82%-
Northern Trust Extended Eq Market Idx1.48M2.66%247.52K
NT Ext Equity Mkt Idx Fd - L1.48M2.66%247.52K
L&G Artificial Intelligence ETF1.30M2.33%4.48K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 04, 2024Coen Steven P. See remarksSell$2.52K
Nov 04, 2024Dmytruk Mark E. See remarksSell$10.02K
Oct 04, 2024Coen Steven P. See remarksSell$2.56K
Oct 04, 2024Dmytruk Mark E. See remarksSell$10.16K
Sep 12, 2024Coen Steven P. See remarksSell$1.95K

Insider Transactions Trends


DateBuySell
2024 Q4-4
2024 Q3-6
2024 Q227
2024 Q1-5
2023 Q4-80

DNA Ownership FAQ


Who Owns Ginkgo Bioworks?

Ginkgo Bioworks shareholders are primarily institutional investors at 46.14%, followed by 6.44% insiders and 47.42% retail investors. The average institutional ownership in Ginkgo Bioworks's industry, Biotech Stocks , is 44.97%, which Ginkgo Bioworks exceeds.

Who owns the most shares of Ginkgo Bioworks?

Ginkgo Bioworks’s largest shareholders are Blackrock (42.01M shares, 2.10%), Two sigma advisers, lp (31.44M shares, 1.57%), and Two sigma investments, lp (19.41M shares, 0.97%). Together, they hold 4.63% of Ginkgo Bioworks’s total shares outstanding.

Does Blackrock own Ginkgo Bioworks?

Yes, BlackRock owns 2.10% of Ginkgo Bioworks, totaling 42.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.04M$. In the last quarter, BlackRock decreased its holdings by -30.851M shares, a -42.34% change.

Who is Ginkgo Bioworks’s biggest shareholder by percentage of total assets invested?

Boston standard wealth management is Ginkgo Bioworks’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 606.63K Ginkgo Bioworks shares, valued at 203K$.

Who is the top mutual fund holder of Ginkgo Bioworks shares?

MS INVF US Growth I is the top mutual fund holder of Ginkgo Bioworks shares, with 12.38% of its total shares outstanding invested in 6.88M Ginkgo Bioworks shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools